{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-048915","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.610377+00:00","generated_at":"2026-05-21T04:31:27.387761+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Traws Pharma Q1 net income $21.5M on warrant gain; cash $15.9M; CEO transition","bullets":["Net income of $21.5M ($2.17 basic EPS) driven by $26.5M gain from warrant liability fair value change; revenue $57K.","Cash and equivalents $15.9M as of Mar 31, 2025, down from $21.3M; runway into Q1 2026.","Submitted FDA briefing package for tivoxavir marboxil (TXM) under Animal Rule; ratutrelvir briefing package planned Q2 2025.","Iain Dukes named Interim CEO after retirement of Werner Cautreels; Jack Stover appointed Chairman.","R&D expense $2.5M (+$0.6M YoY) on virology program; G&A $2.8M (-$0.6M YoY) on lower consulting fees."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-048915","json":"https://secwatch.observer/filing/0001104659-25-048915.json","markdown":"https://secwatch.observer/filing/0001104659-25-048915.md","text":"https://secwatch.observer/filing/0001104659-25-048915.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925048915/0001104659-25-048915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925048915/tm2515069d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:31:27.387761+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}